— Know what they know.
Not Investment Advice

BSEM

BioStem Technologies, Inc.
1W: -4.3% 1M: -15.2% 3M: +23.3% YTD: +25.5% 1Y: -52.2% 3Y: +63.5% 5Y: +251.4%
$4.92
-0.20 (-3.91%)
After Hours: $4.95 (+0.03, +0.61%)
OTC · Healthcare · Biotechnology · $82.5M · Alpha Radar Sell · Power 42
Smart Money Score
No convergence signal
Key Statistics
Market Cap$82.5M
52W Range3.093-15.74
Volume87,993
Avg Volume111,411
Beta-0.00
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOJason V. Matuszewski
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2015-03-17
2836 Center Port Circle
Pompano Beach, FL 33064
US
954 380 8342
About BioStem Technologies, Inc.

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms